• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性肾输尿管切除术后上尿路尿路上皮癌患者膀胱内复发不良病理类型的危险因素

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy.

作者信息

Zhu Jun, Zhang Xiaoqing, Yu Wei, Li Xuesong, He Zhisong, Zhou Liqun, Zhang Zhongyuan, Xiong Gengyan

机构信息

Department of Urology, Peking University First Hospital, Beijing, China.

出版信息

Front Oncol. 2022 Apr 13;12:834692. doi: 10.3389/fonc.2022.834692. eCollection 2022.

DOI:10.3389/fonc.2022.834692
PMID:35494036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9043951/
Abstract

BACKGROUND

Numerous studies have investigated the risk factors of intravesical recurrence (IVR) after radical nephroureterectomy (RNU) in patients with upper urinary tract urothelial carcinoma (UTUC). However, few studies explore the predictors for unfavorable pathological types of IVR following RNU.

METHODS

We retrospectively reviewed 155 patients diagnosed with bladder cancer (BC) following RNU. Binary logistic regression was used for the univariable and multivariable analyses. Nomograms were developed based on the multivariable analysis. The concordance index (C-index) was used to assess the performance of the nomograms. We performed internal validation by generating calibration plots.

RESULTS

Muscle-invasive BC (MIBC) was significantly correlated with operation interval (p = 0.004) and UTUC T-stage (p = 0.016). Operation interval (p = 0.002) and UTUC T-stage (p = 0.028) were also risk factors for BC > 3 cm. UTUC grade (p = 0.015), operation interval (p = 0.003), and hydronephrosis (p = 0.049) were independent predictors for high-grade BC (HGBC). MIBC (p = 0.018) and surgical approach (p = 0.003) were associated with multifocal IVR. Besides, MIBC and HGBC were associated with UTUC grade (p = 0.009), operation interval (p = 0.001), and hydronephrosis (p = 0.023). Moreover, only operation interval (p = 0.036) was a predictor for BC with at least one unfavorable pathological type. We developed nomograms for MIBC, HGBC, BC > 3 cm, and MIBC and/or HGBC. The calibration curves of the nomograms showed good agreement between the observation and prediction cases. The C-indexes of the nomograms were 0.820 (95% CI, 0.747-0.894), 0.728 (95% CI, 0.649-0.809), 0.770 (95% CI, 0.679-0.861), and 0.749 (95% CI, 0.671-0.827), respectively.

CONCLUSIONS

The current study found that operation interval, UTUC T-stage, UTUC grade, surgical approach, and hydronephrosis are independent predictors for unfavorable pathological types of IVR following RNU. Nomograms based on these predictors were developed and internally validated to assess the risk of developing unfavorable pathological types of IVR. Furthermore, patients at high risk of developing unfavorable pathological types BC may benefit from more active follow-up 1 year after RNU by early detection of IVR.

摘要

背景

众多研究已对肾盂输尿管癌(UTUC)患者根治性肾输尿管切除术(RNU)后膀胱内复发(IVR)的危险因素进行了调查。然而,很少有研究探讨RNU后IVR不良病理类型的预测因素。

方法

我们回顾性分析了155例RNU术后诊断为膀胱癌(BC)的患者。采用二元逻辑回归进行单变量和多变量分析。基于多变量分析绘制列线图。一致性指数(C指数)用于评估列线图的性能。我们通过生成校准图进行内部验证。

结果

肌层浸润性膀胱癌(MIBC)与手术间隔(p = 0.004)和UTUC T分期(p = 0.016)显著相关。手术间隔(p = 0.002)和UTUC T分期(p = 0.028)也是BC>3 cm的危险因素。UTUC分级(p = 0.015)、手术间隔(p = 0.003)和肾积水(p = 0.049)是高级别膀胱癌(HGBC)的独立预测因素。MIBC(p = 0.018)和手术方式(p = 0.003)与多灶性IVR相关。此外,MIBC和HGBC与UTUC分级(p = 0.009)、手术间隔(p = 0.001)和肾积水(p = 0.023)相关。此外,只有手术间隔(p = 0.036)是至少有一种不良病理类型BC的预测因素。我们绘制了MIBC、HGBC、BC>3 cm以及MIBC和/或HGBC的列线图。列线图的校准曲线显示观察病例和预测病例之间具有良好的一致性。列线图的C指数分别为0.820(95%CI,0.747 - 0.894)、0.728(95%CI,0.649 - 0.809)、0.770(95%CI,0.679 - 0.861)和0.749(95%CI,0.671 - 0.827)。

结论

本研究发现手术间隔、UTUC T分期、UTUC分级、手术方式和肾积水是RNU后IVR不良病理类型的独立预测因素。基于这些预测因素绘制了列线图并进行了内部验证,以评估发生IVR不良病理类型的风险。此外,具有发生不良病理类型BC高风险的患者可能会从RNU术后1年通过早期检测IVR进行更积极的随访中获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/9043951/d4568a31acd8/fonc-12-834692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/9043951/4020cc40130b/fonc-12-834692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/9043951/d4568a31acd8/fonc-12-834692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/9043951/4020cc40130b/fonc-12-834692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/9043951/d4568a31acd8/fonc-12-834692-g002.jpg

相似文献

1
Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy.根治性肾输尿管切除术后上尿路尿路上皮癌患者膀胱内复发不良病理类型的危险因素
Front Oncol. 2022 Apr 13;12:834692. doi: 10.3389/fonc.2022.834692. eCollection 2022.
2
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.上尿路尿路上皮癌肌层浸润性复发的临床病理特征。
Cancer Sci. 2021 Mar;112(3):1084-1094. doi: 10.1111/cas.14782. Epub 2021 Jan 11.
3
Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.根治性肾输尿管切除术治疗非转移性上尿路上皮癌患者膀胱内复发的预后列线图的建立和验证。
World J Urol. 2020 Aug;38(8):1969-1975. doi: 10.1007/s00345-019-02985-3. Epub 2019 Oct 25.
4
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.根治性肾输尿管切除术(RNU)后膀胱内复发的预测:临床决策工具的开发。
Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19.
5
Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.术前单核细胞与淋巴细胞比值预测根治性肾输尿管切除术无膀胱癌史的上尿路上皮癌患者术后膀胱内复发。
Clin Genitourin Cancer. 2021 Jun;19(3):e156-e165. doi: 10.1016/j.clgc.2020.09.004. Epub 2020 Sep 18.
6
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.根治性肾输尿管切除术治疗后局限性上尿路上皮癌患者膀胱内复发的危险因素和肿瘤学结果:一项倾向评分匹配的病例对照研究。
Int J Surg. 2020 Apr;76:28-34. doi: 10.1016/j.ijsu.2020.02.015. Epub 2020 Feb 17.
7
The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.诊断性输尿管镜检查对上尿路尿路上皮癌患者行肾输尿管切除术后膀胱内复发的影响。
Urol Int. 2021;105(3-4):291-297. doi: 10.1159/000511650. Epub 2020 Dec 2.
8
Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?Xylinas 列线图在亚洲人群中用于预测原发性上尿路上皮癌根治性肾输尿管切除术后的膀胱内复发风险是否准确?
Jpn J Clin Oncol. 2021 Mar 3;51(3):469-477. doi: 10.1093/jjco/hyaa138.
9
Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的预测因素:一项全国多中心分析
Clin Genitourin Cancer. 2017 Dec;15(6):e1055-e1061. doi: 10.1016/j.clgc.2017.07.009. Epub 2017 Jul 22.
10
Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study.开发并验证一种新的列线图预测根治性肾输尿管切除术术后膀胱内复发:一项多中心研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11223-11231. doi: 10.1007/s00432-023-05016-2. Epub 2023 Jun 24.

引用本文的文献

1
Upper tract urothelial carcinoma accompanied by hyperthermia: A case report.上尿路尿路上皮癌伴高热:一例报告。
Urol Case Rep. 2023 Dec 5;52:102634. doi: 10.1016/j.eucr.2023.102634. eCollection 2024 Jan.
2
Evaluation of the diagnostic efficiency of voided urine fluorescence hybridization for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma.评估排尿荧光杂交技术对术前“低危”上尿路尿路上皮癌病理诊断的效能
Front Oncol. 2023 Jul 27;13:1225428. doi: 10.3389/fonc.2023.1225428. eCollection 2023.

本文引用的文献

1
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).微创肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的危险因素(ROBUUST 协作组)。
J Urol. 2021 Sep;206(3):568-576. doi: 10.1097/JU.0000000000001786. Epub 2021 Apr 21.
2
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis.吸烟习惯对接受根治性膀胱切除术治疗尿路上皮膀胱癌患者围手术期发病率的影响:系统评价和荟萃分析。
Eur Urol Oncol. 2021 Aug;4(4):580-593. doi: 10.1016/j.euo.2020.10.006. Epub 2020 Nov 5.
3
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
4
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南:2020 年指南摘要。
Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29.
5
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.根治性肾输尿管切除术治疗后局限性上尿路上皮癌患者膀胱内复发的危险因素和肿瘤学结果:一项倾向评分匹配的病例对照研究。
Int J Surg. 2020 Apr;76:28-34. doi: 10.1016/j.ijsu.2020.02.015. Epub 2020 Feb 17.
6
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
7
Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.根治性肾输尿管切除术治疗上尿路上皮癌后无膀胱癌病史患者术前脓尿预测膀胱内复发。
Clin Genitourin Cancer. 2020 Apr;18(2):e167-e173. doi: 10.1016/j.clgc.2019.09.017. Epub 2019 Sep 27.
8
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.欧洲泌尿外科学会非肌肉浸润性膀胱癌(TaT1 和原位癌)指南 - 2019 年更新版。
Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20.
9
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
10
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.诊断性输尿管镜检查对上尿路尿路上皮癌根治性肾输尿管切除术患者膀胱内复发的影响:一项系统评价和荟萃分析。
BJU Int. 2017 Sep;120(3):313-319. doi: 10.1111/bju.13935. Epub 2017 Jul 19.